Skip to content
1st Counsel – Lifestyle
Author:
Business Wire
YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm
March 28, 2026
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
March 28, 2026
Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.
March 28, 2026
PRTH Investors Have the Opportunity to Join Investigation of Priority Technology Holdings, Inc. with the Schall Law Firm
March 28, 2026
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
March 28, 2026
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 28, 2026
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
March 28, 2026
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
March 28, 2026
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
March 28, 2026
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
March 28, 2026
←
Previous Page
1
…
3,980
3,981
3,982
3,983
3,984
…
4,647
Next Page
→